Non HDL-C as the Primary Target for LipidLowering Therapy: Moving beyond LDLCentric Management
Journal Title: Indian Journal of Cardio Biology & Clinical Sciences - Year 2015, Vol 2, Issue 1
Abstract
The value of lowering low-density lipoprotein cholesterol (LDL-C) is widely known with a large number of studies demonstrating benefit of LDL-C lowering in a wide range of patient populations. Accordingly, LDL-C has been the focus of lipid lowering therapy for a long period. However, recent data suggest that non-high density lipoprotein cholesterol (non-HDL-C) may be a better target for lipid management than LDL-C. Unlike LDL-C, non-HDL-C includes all atherogenic particles present in blood and therefore provides more complete estimation of cardiovascular risk, esp. in patients with atherogenic dyslipidemia or those already on statin therapy. Further, measurement of non-HDL-C is simple, no extra blood test is required and there is no need for fasting sampling.
Authors and Affiliations
Manish Bansal
Keywords
Related Articles
- EP ID EP195113
- DOI -
- Views 95
- Downloads 0
Potential Future Therapies of Myocardial Ischemia Reperfusion Injury
Cardiovascular diseases are one of the leading causes of death in the world. Angioplasty, heart transplantation, thrombolysis, and coronary bypass are general treatment approaches of cardiovascular diseases. All of these...
Genetic Aspect of Clopidogrel Resistance: An Indian Scenario
Clopidogrel is an oral, thienopyridine class anti-platelet agent used to inhibit blood clots and is one of the most widely used in patients with coronary artery disease, peripheral vascular diseases, and cerebrovascular...
Non HDL-C as the Primary Target for LipidLowering Therapy: Moving beyond LDLCentric Management
The value of lowering low-density lipoprotein cholesterol (LDL-C) is widely known with a large number of studies demonstrating benefit of LDL-C lowering in a wide range of patient populations. Accordingly, LDL-C has been...
Prevalence of Genetic Variations Affecting Warfarin Action from Different Parts of India
Warfarin, an anticoagulant is used in patients who are at increased risk of developing blood clots. The management of warfarin therapy is challenging because it shows large inter-individual variability in patient’s respo...
From Reperfusion to Regeneration and Beyond
The pathophysiology of AMI is a thrombotic occlusion of coronary artery leading to death of heart muscles. The treatment therefore aims at restoration of the blood supply by reopening the artery that can be achieved phar...